You are here

  • Home
  • Archive
  • Volume 12, Issue 4
  • Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma

 

Online download statistics by month:

Online download statistics by month: April 2024 to February 2026

AbstractFullPdf
Apr 2024605614308
May 2024362366192
Jun 2024195198103
Jul 202418118484
Aug 202413213376
Sep 202414915173
Oct 202417617882
Nov 202412312459
Dec 202421021072
Jan 202514814985
Feb 202517617672
Mar 202513613695
Apr 202517317399
May 202513413580
Jun 202510310748
Jul 2025110
Sep 2025550
Jan 2026001
Feb 2026100
Total301030401529